We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...

Abbott Laboratories (NYSE:ABT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” ...

We recently compiled a list of the Jim Cramer Shed Light on These 10 Stocks. In this article, we are going to take a look at ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

According to Benzinga Pro, Abbott Laboratories's peer group average for short interest as a percentage of float is 3.78%, ...

The stock's fall snapped a three-day winning streak.

His fears were that Abbott (NYSE:ABT) might pull the product entirely rather than risk further lawsuits—just like Johnson & ...

Abbott Laboratories had a return on equity of 20.74% and a net margin of 31.95%. Abbott Laboratories’s quarterly revenue was up 7.2% on a year-over-year basis.

The last few weekends have been roiled by headlines. Here's why we took a different direction on this medical stock this week ...

February 11, 2025 records indicate that Representative Emily Randall filed a sale of Abbott Laboratories ABT, valued between $11,011 and $165,000. According to the February filing, the transaction ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...